AIM
ALPN

Acrospire Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Acrospire Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-300
Closed -$3K – 1544
2017
Q2 		$3K Sell
300
-2,978
-91% -$28.5K ﹤0.01% 2040
2017
Q1 		$38K Sell
3,278
-1,144
-26% -$11.6K 0.03% 1190
2016
Q4 		$40K Buy
+4,422
New +$88.1K 0.02% 1513

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrospire Investment Management's ALPN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2017, closing a stake of 300 shares — an estimated $3K sold.

Acrospire Investment Management first reported a position in ALPN in Q4 2016 and held it in 3 quarters. The position peaked at $40K in Q4 2016. 24 funds tracked by Wall St. Rank hold ALPN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 300 Alpine Immune Sciences Inc shares in Q3 2017, an estimated $3K.
  • Acrospire Investment Management first reported a position in Alpine Immune Sciences Inc in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Alpine Immune Sciences Inc position peaked at $40K in Q4 2016.
  • 24 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.